As a shareholder and owner of Vical Corporation, I must admit I am extremely disappointed by recent developments with regards to the Allovectin trial.
As an employer, I am extremely disappointed by the lack of sincerity, consideration and regret shown with regards to how this trial concluded. It is my personal belief employee Vijay Samant is not fit to run Vical and thru his leadership, has caused extreme financial hardship to the owners of this corporation. Further, I believe he provides no clear vision of leadership, therefore I request Vijay Samant be removed from position of CEO. I also believe no further compensation or severance package should be honored with this employee, due to lack of performance. I believe this money could be better spent trying to right my corporation.
As your employer, I further demand that all documentation with regards to the Allovectin phase 3 trial results be published and/or provided to shareholders in order to garner a more professional opinion. In addition, I formally request that the Allovectin 3 trial results be provided to a separate, independent firm for statistical analysis and recommendation. I formally request these actions due to lack of confidence within my own corporation.